Minerva Surgical (UTRS) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock UTRS vs. NMRD, VIVE, MOTS, DRTSW, ANZUW, IONM, ATAKW, BBLGW, BRSHW, and BRSHShould you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Nemaura Medical (NMRD), Viveve Medical (VIVE), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Bruush Oral Care (BRSH). These companies are all part of the "medical equipment" industry. Minerva Surgical vs. Nemaura Medical Viveve Medical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics Bruush Oral Care Bruush Oral Care Nemaura Medical (NASDAQ:NMRD) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, community ranking, dividends, profitability, valuation, media sentiment and analyst recommendations. Is NMRD or UTRS more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Minerva Surgical N/A N/A N/A Which has more risk and volatility, NMRD or UTRS? Nemaura Medical has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 3.92, indicating that its stock price is 292% more volatile than the S&P 500. Do institutionals & insiders believe in NMRD or UTRS? 4.4% of Nemaura Medical shares are owned by institutional investors. 40.4% of Nemaura Medical shares are owned by company insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in NMRD or UTRS? Minerva Surgical received 3 more outperform votes than Nemaura Medical when rated by MarketBeat users. However, 57.14% of users gave Nemaura Medical an outperform vote while only 41.18% of users gave Minerva Surgical an outperform vote. CompanyUnderperformOutperformNemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Minerva SurgicalOutperform Votes741.18% Underperform Votes1058.82% Which has better valuation & earnings, NMRD or UTRS? Nemaura Medical has higher earnings, but lower revenue than Minerva Surgical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K1.34-$14.14M-$0.390.00Minerva Surgical$51.69M0.00-$34.11MN/AN/A Does the media refer more to NMRD or UTRS? In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral Minerva Surgical Neutral SummaryNemaura Medical beats Minerva Surgical on 4 of the 7 factors compared between the two stocks. Get Minerva Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTRS vs. The Competition Export to ExcelMetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$4.41B$5.31B$8.42BDividend YieldN/A43.63%5.21%4.10%P/E RatioN/A29.2326.7819.69Price / SalesN/A65.60386.97118.34Price / CashN/A51.0838.2534.62Price / BookN/A6.206.744.50Net Income-$34.11M$67.60M$3.23B$248.32M Minerva Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160NMRDNemaura MedicalN/AN/AN/AN/A$4,000.00$3,017.000.0040VIVEViveve MedicalN/AN/AN/A-66.7%$2,000.00$6.83M0.0070MOTSMotus GIN/AN/AN/A-99.7%$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.23flatN/A+13.1%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.03flatN/AN/A$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130ATAKWAurora Technology AcquisitionN/A$0.01flatN/A-69.8%$0.00N/A0.00N/ABBLGWBone BiologicsN/A$13.50-20.1%N/A-61.5%$0.00N/A0.002Gap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011BRSHBruush Oral CareN/A$0.00flatN/A-99.6%$0.00$2.92M0.0011 Related Companies and Tools Related Companies Nemaura Medical Alternatives Viveve Medical Alternatives Motus GI Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Assure Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives Bruush Oral Care Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTRS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
